GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Xinbang Pharmaceutical Co Ltd (SZSE:002390) » Definitions » Buildings And Improvements

Guizhou Xinbang Pharmaceutical Co (SZSE:002390) Buildings And Improvements : ¥0 Mil (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Guizhou Xinbang Pharmaceutical Co Buildings And Improvements?

Guizhou Xinbang Pharmaceutical Co Buildings And Improvements Historical Data

The historical data trend for Guizhou Xinbang Pharmaceutical Co's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhou Xinbang Pharmaceutical Co Buildings And Improvements Chart

Guizhou Xinbang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Guizhou Xinbang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Guizhou Xinbang Pharmaceutical Co Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

Guizhou Xinbang Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guizhou Xinbang Pharmaceutical Co Ltd (SZSE:002390) » Definitions » Buildings And Improvements
Comparable Companies
SHSE:600976 SZSE:002755 SHSE:600664 SZSE:300705 SZSE:300725 SHSE:600252 SZSE:000989 SHSE:600993 SZSE:000650 SHSE:600285 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
6th Floor, Kekai 1st Court, Intersection of Aerospace Avenue and Xintian Avenue, Wudang District, Guiyang, CHN
Website
http://www.xinbang.com
Guizhou Xinbang Pharmaceutical Co Ltd is a China-based pharmaceutical company. The company is engaged in providing medical services and pharmaceutical distribution. The scope of business also covers the cultivation of Chinese herbal medicines, production of Chinese herbal medicines and Chinese patent medicines, research and development, production and sales of biological drugs, and other fields.
Executives
An Ji Director
Gao Wen Lin Executives
Lu Ya Fang Executives
Xu Qi Directors, executives
An Huai Lve Director
Ma Cheng Director
Zhang Jie Qing Directors, executives
Kong Ling Zhong Directors, executives
Liu Xiao Yang Executives
Xiao Ya Yun Executives
Yang Pei Executives
Zhang Guan Fu Director
Chen Chuan Directors, executives
He Wen Jun Supervisors
Lv Yu Tao Director

Guizhou Xinbang Pharmaceutical Co Headlines

No Headlines